David-Alexandre C. Gros - 09 Jun 2021 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for David-Alexandre Gros
Issuer symbol
ELDN
Transactions as of
09 Jun 2021
Net transactions value
+$24,030
Form type
4
Filing time
10 Jun 2021, 17:25:51 UTC
Next filing
19 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELDN Common Stock Purchase $24,030 +3,000 $8.01* 3,000 09 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 reports an open market purchase by the Reporting Person of shares of common stock in accordance with the Issuer's trading policies.